# Reproductive System & Gynecology & Andrology

## Genital Tract Embryology

|Primordial|Female|Male|
|-|-|-|
|Gubernaculum|Ovarian ligament<br>Round ligament|-|
|Processus vaginalis|-|Tunica vaginalis|
|Undifferentiated gonads|Ovary|Testis|
||Theca cell|Leydig cell|
||Granulosa cell|Sertoli cell|
|Genital ducts|Frimbriae|Epididymis|
||Fallopian tube|Vas deferens|
||Uterus|Seminal vesicle|
||Upper vagina|Ejaculatory duct|
|Urogenital sinus|Lower vagina|Prostatic utricle|
||Paraurethral gland of Skene|Prostate gland|
||Greater vestibular gland of Bartholin|Bulbourethral gland of Cowper|
|Urogenital fold|Mons pubis|Dorsal penile shaft|
||Labia minora|Ventral penile shaft|
|Labioscrotal swelling|Labia majora|Scrotum|
|Genital tubercle|Clitoris|Penis|

## Ligaments of Uterus and Ovary

|Ligament|Connects|Contents|
|-|-|-|
|Broad ligament|Uterus ~ Pelvis :: lateral|-|
|Round ligament|Uterus ~ Labia majora|Gubernaculum|
|Ovarian ligament|Uterus ~ Ovary|Gubernaculum|
|Infundibulopelvic [Suspensory] ligament|Ovary ~ Pelvis :: lateral|Ovarian vessels|
|Pubocervical ligament|Cervix ~ Pubis|-|
|Cardinal ligament|Cervix ~ Pelvis :: lateral|Uterine vessels|
|Uterosacral ligament|Cervix ~ Sacrum|Inferior hypogastric plexus|

![](../Figures/Ligaments%20of%20Uterus%20and%20Ovary.png)

## Sex Hormone Production

|Hormones|Regulation|Female|Male|
|-|-|-|-|
|Progesterone<br>DHEA<br>Androstenedione<br>Testosterone|ACTH|Adrenal gland|Adrenal gland|
|Progesterone<br>Testosterone|LH|Corpus luteum<br>Theca cells|Leydig cells|
|Anti-Mullerian hormone (AMH)<br>Estradiol<br>Inhibin|FSH|Corpus luteum<br>Granulosa cells|Sertoli cells|
|Estrone|-|Adipocytes|Adipocytes|
|Dihydrotestosterone (DHT)|-|Peripheral cells|Peripheral cells|

## Estrogens in Females

|Estrogen|Estrogen Site|Precursor|Precursor Site|Enzyme|Timing|
|-|-|-|-|-|-|
|Estrone|Adipocytes|Androstenedione|Adrenal gland|Aromatase|Post-menopause|
|Estradiol|Granulosa cells|Testosterone|Theca cells|Aromatase|Non-pregnancy|
|Estriol|Placenta|DHEA sulfate (DHEAS)|Adrenal gland|Sulfatase|Pregnancy|

## Etiology of Incresed Exposure to Estrogen

- Nulliparity
- Early menarche
- Late menopause

## Side Effects of Unopposed Estrogen

- ↑ Thromboembolic events
- ↑ Breast cancer
- ↑ Endometrial cancer
- ↑ Bone mineral density

## Sexual Development

|Female|Male|
|-|-|
|Thelarche|Gonadarche|
|Pubarche|Pubarche|
|Growth spurt|Adrenarche|
|Menarche|Growth spurt|

## Age of Onset of Puberty

|Sex|Age (years)|
|-|-|
|Female|8 ~ 13|
|Male|9 ~ 14|

## Etiology of Peripheral Precocious Puberty

- Congenital adrenal hyperplasia
- Adrenal tumors
- Gonadal tumors
- McCune-Albright syndrome
- Exogenous sex hormone

## Etiology of Abnormal Uterine Bleeding (AUB) {PALM-COEIN}

- Pregnancy
- Polyps
- Adenomyosis
- Leiomyoma
- Malignancy
- Coagulopathy
- Ovulatory dysfunction
- Endometrium
- Iatrogenic
- Not yet classified

## Classification of Amenorrhea

- Primary: no menarche by age 15 years
- Secondary: no menses for ≥ 3 cycles / ≥ 6 months

## Etiology of Primary Amenorrhea

|Etiology|Breast|Uterus|Ovary|
|-|-|-|-|
|Outflow obstruction|+|+|+|
|Anorexia nervosa|+|+|+|
|Mullerian agenesis|+|-|+|
|Androgen insensitivity syndrome (AIS)|+|-|-|
|Constitutional growth delay|-|+|+|
|Hypogonadotropic Hypogonadism|-|+|+|
|Turner syndrome|-|+|+|
|Swyer syndrome|-|+|-|

## Etiology of Secondary Amenorrhea

|Etiology|GnRH|LH & FSH|SH|
|-|-|-|-|
|Pregnancy|↓|↓|↑|
|Menopause [Ovarian failure]|↑|↑|↓|
|Resistant ovary [Savage] syndrome|↑|↑|↓|
|Hypogonadotropic Hypogonadism|↓|↓|↓|
|Polycystic ovary syndrome (PCOS)|↑/↓|↑/↓|↓/↑|
|Asherman syndrome|-|-|-|
|Outflow obstruction|-|-|-|

## Presentation of Turner Syndrome

- Streak gonads
- Amenorrhea
- Webbed neck
- Shield chest
- Bicuspid aortic valve
- Coarctation of the aorta
- Cystic hygroma

## Indicators of Ovarian Reserve

|Indicator|Normal|
|-|-|
|FSH :: follicular phase|2 ~ 8|
|Anti-Mullerian hormone (AMH)|1 ~ 5|
|Antral follicle count (AFC)|5 ~ 10|

## Presentation of Menopause {HAVOCS}

- Hot flashes
- Atrophy of the vagina
- Osteoporosis
- Cardiovascular disease
- Sleep disturbances

## Treatment of Menopause

- Topical estrogen
- Hormone replacement therapy (HRT)
- SSRIs & SNRIs
- Calcium & Vitamin D supplements

## Side Effects of Hormone Replacement Therapy (HRT)

- ↑ Thromboembolic events
- Breast cancer
  - ↑ if estrogen + progesterone
  - ↓ if estrogen alone
- Endometrial cancer
  - ↓ if estrogen + progesterone
  - ↑ if estrogen alone
- ↓ Fractures

## Hormones Changes in PCOS

|Hormone|Changes|
|-|-|
|GnRH|↑/↓|
|LH|↑|
|FSH|↓|
|LH/FSH|↑|
|Progesterone|↓|
|Testosterone|↑|
|Estrogen|↑|

## Rotterdam Criteria for Diagnosis of PCOS

- Anovulation
- Hyperandrogenism
- Polycystic ovaries

## Treatment of PCOS

- Ovulation induction
  - Estrogen modulators :: Clomiphene
  - Aromatase inhibitors
- Combined hormonal contraception
- Androgen antagonists
- 5α-Reductase inhibitors
- Metformin ± Statins
- Lifestyle modification

## Non-surgical Treatment of Pelvic Organ Prolapse (POP)

- Kegel exercise
- Topical estrogen
- Pessary

## Pathogens of Genital Tract Infection

|Pathogen|Presentation|Treatment|
|-|-|-|
|Neisseria gonorrhoeae|Discharge :: greenish-yellow<br>Pelvic inflammatory disease (PID)|3° Cephalosporins<br>Macrolides|
|Haemophilus ducreyi|Painful chancroid|-|
|Klebsiella granulomatis|Granuloma inguinale|Macrolides<br>Doxycycline|
|Treponema pallidum|Painless chancre<br>Condyloma lata|Penicillin|
|Chlamydia trachomatis|Discharge :: greenish-yellow<br>Lymphogranuloma venereum (LGV)<br>Pelvic inflammatory disease (PID)|Macrolides<br>Doxycycline|
|Gardnerella vaginalis|Discharge :: grayish & fishy|Metronidazole|
|Candida albicans|Discharge :: white & curdy|-Conazoles|
|Trichomonas vaginalis|Discharge :: greenish-yellow & frothy|Metronidazole|
|HPV|Condyloma accumulata<br>Verruca vulgaris|-|
|HSV|Paniful ulcers|-|

## Comparison Between Testicular Torsion and Epididymitis

||Testicular Torsion|Epididymitis|
|-|-|-|
|Prehn sign|-|+|
|Cremasteric reflex|-|+|
|Blood flow|↓|↑|

## Medications for BPH

|Mechanism|Medication|
|-|-|
|α<sub>1</sub> antagonists|Tamsulosin<br>Terazosin<br>Doxazosin<br>Prazosin|
|5α-Reductase inhibitors|Finasteride|

## Reproductive Tumors

### Epithelial Tumors

- Serous cystadenoma<br>cystadenocarcinoma
- Mucinous cystadenoma<br>cystadenocarcinoma
- Endometrioid carcinoma
- Clear cell carcinoma
- Mixed cell carcinoma
- Transitional cell carcinoma [Brenner tumor]
- Carcinosarcoma [Malignant mixed Mullerian tumor (MMMT)]

### Stromal Tumors

|Female|Male|Markers|
|-|-|-|
|Theca cell tumor [Thecoma]|Leydig cell tumor|-|
|Granulosa cell tumor|Sertoli cell tumor|Inhibin|
|Fibroma|Fibroma|-|

### Germ Cell Tumors (GCT)

|Female|Male|Markers|
|-|-|-|
|Dysgerminoma|Seminoma|ALP & LDH|
|Choriocarcinoma|Choriocarcinoma|hCG|
|Endodermal sinus tumor (EST)|Endodermal sinus tumor (EST)|AFP|
|Embryonal carcinoma|Embryonal carcinoma|hCG & AFP|
|Teratoma|Teratoma|hCG & AFP|

## Triad of Meigs Syndrome

- Ovarian fibroma
- Pleural effusion
- Ascites

## Types of Endometrial Cancer

|Type|1|2|
|-|-|
|Histology|Endometrioid|Non-endometrioid|
|Risk factors|Estrogen|-|
|Prognosis|Favorable|Poor|

## Bethesda System for Pap Smear Results

- Squamous cell abnormalities
  - Atypical squamous cell (ASC)
  - Low-grade squamous intraepithelial lesion (LSIL)
  - High-grade squamous intraepithelial lesion (HSIL)
  - Squamous cell carcinoma
- Glandular cell abnormalities
  - Atypical glandular cell (AGC)
  - Adenocarcinoma in situ (AIS)
  - Adenocarcinoma

![](../Figures/Bethesda%20System%20for%20Pap%20Smear%20Results.jpg)

## Management of Abnormal Pap Smear Results

|Result|Age (years)|HPV|Management|
|-|-|-|-|
|-|< 30|±/?|Routine screening|
|-|> 30|-/?|Routine screening|
|-|> 30|+|Repeat screening in 1 year|
|ASC-US|< 25|-|Routine screening|
|ASC-US|< 25|+/?|Repeat screening in 1 year|
|ASC-US|> 25|-|Repeat screening in 3 years|
|ASC-US|> 25|?|Repeat screening in 1 year|
|LSIL|< 25|±/?|Repeat screening in 1 year|
|LSIL|> 25|-|Repeat screening in 1 year|
|Consecutive<br>Otherwise|Any|±/?|Colposcopy ± Biopsy|

## Management of Cervical Intraepithelial Neoplasia (CIN)

|CIN|Management|
|-|-|
|I|Repeat screening in 1 year|
|II<br>III|Cryotherapy<br>Laser ablation<br>Conization<br>Loop electrosurgical excision procedure (LEEP)|

## Management of Seminoma

- Radical orchiectomy
- Radiotherapy
- Chemotherapy

## Contraception Methods

- Barrier contraception
- Combined hormonal contraception
  - Oral contraceptive pills (OCPs)
  - Contraceptive patch
  - contraceptive ring
- Depot medroxyprogesterone
- Progestin subdermal implant
- Intrauterine devices
  - Progestin intrauterine device
  - Copper intrauterine device

## Side Effects of Combined Hormonal Contraception

- ↑ Thromboembolic events
- ↑ Breast cancer
- ↓ Endometrial cancer
- ↓ Ovarian cancer

## Contraindications to Combined Hormonal Contraception

- Age ≥ 35 years<br>Smoking ≥ 15 cigarettes/day
- History of thromboembolic events
- Active breast cancer
- Liver failure
- Migraines with aura

## Contraindications to Intrauterine Device (IUD)

- Pregnancy
- Unexplained vaginal bleeding
- Endometrial cancer
- Cervical cancer
- Pelvic inflammatory disease (PID)

## Reference Limits of Semen Analysis

- Volume > 1.5 mL
- Sperm concentration > 15 M/mL
- Total sperm count > 39 M
- Normal forms > 4%
- Vitality > 58%
- Progressive motility > 32%
- Total motility > 40%

## Indications for Assisted Reproductive Technology (ART)

### Intrauterine Insemination (IUI)

- Cervical factors
- Male factors
- Donor sperms

### In Vitro Fertilization (IVF)

- Tubal factors
- Donor eggs
- Genetic screening
- Failed intrauterine insemination (IUI)

## Controlled Ovarian Hyperstimulation

### Suppression of Spontaneous Ovulation

|Protocol|Timing|
|-|-|
|GnRH agonist long protocol|Last luteal phase|
|GnRH agonist short protocol|Menstruation|
|GnRH antagonist protocol|Leading follicle > 14 mm|

### Ovulation Induction

- (Follicles > 18 mm) ≥ 2
- Estradiol per co-dominant follicle > 200 pg/mL

|Mechanism|Medication|
|-|-|-|
|GnRH agonists|Leuprolide|
|hCG agonists|Choriogonadotropin|

![](../Figures/Controlled%20Ovarian%20Hyperstimulation.png)

## Breast Imaging Reporting and Data System (BI-RADS)

|Category|Interpretation|Management|Likelihood of cancer|
|-|-|-|-|
|0|Inconclusive|Repeat|-|
|1|Negative|Routine|0|
|2|Benign|Routine|0|
|3|Probably benign|Every 6 months|< 2%|
|4|Suspicious|Biopsy|2 ~ 95%|
|5|Highly suggestive|Biopsy|> 95%|
|6|Biopsy-proven|-|-|

## Breast Tumors

### Epithelial Tumors

- Fibrocystic change
- Intraductal papilloma
- Ductal carcinoma in situ (DCIS)<br>Invasive ductal carcinoma (IDC)
- Lobular carcinoma in situ (LCIS)<br>Invasive lobular carcinoma (ILC)
- Medullary carcinoma

### Stromal Tumors

- Fibroadenoma
- Phyllodes tumor

![](../Figures/Breast%20Tumors.png)

## Molecular Subtypes of Breast Cancer

|Subtype|Receptors|Mutations|
|-|-|
|Luminal A|PR & ER|-|
|Luminal B|PR & ER|-|
|HER2-enriched|HER2|-|
|Basal-like|-|BRCA|
|Claudin-low|-|BRCA|
|Interferon-rich|-|BRCA|

![](../Figures/Breast%20Cancer%20>%20Molecular%20Subtypes.png)

## Types of Flaps for Breast Reconstruction

- Transverse rectus abdominis myocutaneous (TRAM) flap
- Latissimus dorsi (LD) flap
- Deep inferior epigastric perforator (DIEP) flap
- Superficial inferior epigastric artery (SIEA) flap
- Gluteal flap
- Transverse upper gracilis (TUG) flap
- Profunda artery perforator (PAP) flap
